.Attribute Medication, Released online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Standpoint calls for introduction of clients along with MASLD and dimension of liver end results in cardio-- renal-- metabolic tests, when data recommend mechanistically conceivable perks as well as clinical safety and security-- and also details considerations for test concept as well as regulative commendation.